These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6208054)

  • 41. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
    Maslova MN; Ogorodnikova LE; Titkov IuS
    Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-dependent reversal of digoxin-inhibited activity of an in vitro Na+K+ATPase model by digoxin-specific antibody.
    Cano NJ; Sabouraud AE; Debray M; Scherrmann JM
    Toxicol Lett; 1996 May; 85(2):107-11. PubMed ID: 8650693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High yield-purification of a urinary Na+-pump inhibitor.
    Cloix JF; Crabos M; Wainer IW; Ruegg U; Seiler M; Meyer P
    Biochem Biophys Res Commun; 1985 Sep; 131(3):1234-40. PubMed ID: 2996543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochem Biophys Res Commun; 1987 Dec; 149(2):468-74. PubMed ID: 2827643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
    Inagami T; Tamura M
    Am J Med Sci; 1988 Apr; 295(4):400-5. PubMed ID: 2834953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of an endogenous Na-pump specific inhibitor from normal pig urine: characterization and comparison with the inhibitor purified from bovine adrenal glands.
    Tamura M; Naruse M; Sakakibara M; Inagami T
    Biochim Biophys Acta; 1993 May; 1157(1):15-22. PubMed ID: 8388731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vanadium-diascorbates are strong candidates for endogenous ouabain-like factors in human urine: effects on Na-K-ATPase enzyme kinetics.
    Kramer HJ; Krampitz G; Bäcker A; Krampitz G; Meyer-Lehnert H
    Biochem Biophys Res Commun; 1995 Aug; 213(1):289-94. PubMed ID: 7639747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
    Meyer-Lehnert H; Bäcker A; Kramer HJ
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Schizoid neurochemical pathology-induced membrane Na(+)-K+ ATPase inhibition in relation to neurological disorders.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Dec; 113(12):1705-17. PubMed ID: 14602543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Further evidence for the dissociation of digoxin-like immunoreactivity from Na+,K(+)-ATPase inhibitory activity.
    Yamada K; Goto A; Ishii M; Yoshioka M; Sugimoto T
    Experientia; 1990 Oct; 46(10):1041-3. PubMed ID: 2171976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertension.
    Gonick HC; Weiler EW; Khalil-Manesh F; Weber MA
    Am J Hypertens; 1993 Aug; 6(8):680-7. PubMed ID: 8217031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterogeneity and lability of endogenous digitalis-like substances in the plasma of the toad, Bufo marinus.
    Butler VP; Morris JF; Akizawa T; Matsukawa M; Keating P; Hardart A; Furman I
    Am J Physiol; 1996 Aug; 271(2 Pt 2):R325-32. PubMed ID: 8770130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The search for a hypothalamic Na+,K+-ATPase inhibitor.
    Haber E; Haupert GT
    Hypertension; 1987 Apr; 9(4):315-24. PubMed ID: 2435655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
    Gentile DA; Skoner DP
    Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antagonism by potassium of the inhibition of (Na(+)+K+) ATPase produced by an endogenous digitalis-like compound extracted from mammalian heart.
    Castañeda-Hernández G; Flores-Murrieta FJ
    Arch Med Res; 1992; 23(1):13-7. PubMed ID: 1339224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous "ouabain-like" activity in bovine plasma.
    Tal DM; Katchalsky S; Lichtstein D; Karlish SJ
    Biochem Biophys Res Commun; 1986 Feb; 135(1):1-8. PubMed ID: 3006675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct demonstration of an inhibitor of sodium, potassium dependent adenosine triphosphatase (Na+, K+-ATPase) in plasma from normotensive and hypertensive subjects.
    Roulston JE; Traill K; Wathen CG
    Clin Chim Acta; 1986 Sep; 159(2):163-71. PubMed ID: 3021362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.